Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity
The formation of neutralizing antibodies is a growing concern in the use of botulinum neurotoxin A (BoNT/A) as it may result in secondary treatment failure. Differences in the immunogenicity of BoNT/A formulations have been attributed to the presence of pharmacologically unnecessary bacterial compon...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2024-02-01
|
| Colecção: | Toxins |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2072-6651/16/2/101 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|